Olfactory Mucosa Is a Potential Source for Autologous Stem Cell Therapy for Parkinson’s Disease

Parkinson's disease is a complex disorder characterized by degeneration of dopaminergic neurons in the substantia nigra in the brain. Stem cell transplantation is aimed at replacing dopaminergic neurons because the…

Continue ReadingOlfactory Mucosa Is a Potential Source for Autologous Stem Cell Therapy for Parkinson’s Disease

Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium

Neovascularization induced by vascular endothelial growth factor (VEGF) represents an appealing approach for treating ischemic heart disease. However, VEGF therapy has been associated with transient therapeutic effects and potential risk…

Continue ReadingAutologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium

Autologous Stem Cell Transplantation in Progressive Multiple Sclerosis—An Interim Analysis of Efficacy

Based on the good results of experimental transplantation in animal models of multiple sclerosis and of other autoimmune diseases, we have treated 24 patients suffering from chronic progressive multiple sclerosis…

Continue ReadingAutologous Stem Cell Transplantation in Progressive Multiple Sclerosis—An Interim Analysis of Efficacy